Top

Internal and Emergency Medicine

Published in:

23-03-2022 | CE-Research Letter to the Editor

Comparison of two scores in predicting pulmonary embolism-related adverse events in intermediate–high-risk patients: a systematic review and meta-analysis

Authors: Carlo Bova, Ernesto Vigna, Massimo Gentile, Francesca Serena Pignataro

Published in: Internal and Emergency Medicine | Issue 5/2022

Excerpt

Dear Sir, …

Available only for authorised users

Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, NíÁinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL, ESC Scientific Document Group (2020) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 41(4):543–603. https://doi.org/10.1093/eurheartj/ehz405CrossRefPubMed

Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV, PEITHO Investigators (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 370(15):1402–11. https://doi.org/10.1056/NEJMoa1302097CrossRefPubMed

Chen X, Shao X, Zhang Y, Zhang Z, Tao X, Zhai Z, Wang C (2020) Assessment of the Bova score for risk stratification of acute normotensive pulmonary embolism: a systematic review and meta-analysis. Thromb Res 193:99–106. https://doi.org/10.1016/j.thromres.2020.05.047 (Epub 2020 May 29)CrossRefPubMed

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 151(4):264–9. https://doi.org/10.7326/0003-4819-151-4-200908180-00135CrossRefPubMed

Wells GA, Shea B, O’Connell D, et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis, Available online at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. https://doi.org/10.1136/bmj.327.7414.557CrossRefPubMedPubMedCentral

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634. https://doi.org/10.1136/bmj.315.7109.629CrossRefPubMedPubMedCentral

Vanni S, Nazerian P, Bova C, Bondi E, Morello F, Pepe G, Paladini B, Liedl G, Cangioli E, Grifoni S, Jiménez D (2017) Comparison of clinical scores for identification of patients with pulmonary embolism at intermediate-high risk of adverse clinical outcome: the prognostic role of plasma lactate. Intern Emerg Med 12(5):657–665. https://doi.org/10.1007/s11739-016-1487-6 (Epub 2016 Jun 28)CrossRefPubMed

Barnes GD, Muzikansky A, Cameron S, Giri J, Heresi GA, Jaber W, Wood T, Todoran TM, Courtney DM, Tapson V, Kabrhel C (2020) Comparison of 4 acute pulmonary embolism mortality risk scores in patients evaluated by pulmonary embolism response teams. JAMA Netw Open 3(8):e2010779. https://doi.org/10.1001/jamanetworkopen.2020.10779CrossRefPubMedPubMedCentral

10.

Solverson K, Humphreys C, Liang Z, Prosperi-Porta G, Andruchow JE, Boiteau P, Ferland A, Herget E, Helmersen D, Weatherald J (2021) Rapid prediction of adverse outcomes for acute normotensive pulmonary embolism: derivation of the Calgary Acute Pulmonary Embolism score. ERJ Open Res. 7(2):00879–02020. https://doi.org/10.1183/23120541.00879-2020CrossRefPubMedPubMedCentral

11.

Jimenez D, Lobo JL, Fernandez-Golfin C, Portillo AK, Nieto R, Lankeit M, Konstantinides S, Prandoni P, Muriel A, Yusen RD, PROTECT investigators (2016) Effectiveness of prognosticating pulmonary embolism using the ESC algorithm and the Bova score. Thromb Haemost. 115(4):827–34. https://doi.org/10.1160/TH15-09-0761CrossRefPubMed

12.

Jia D, Ji C, Zhao M (2021) Saddle pulmonary embolism is not a sign of high-risk deterioration in non-high-risk patients: a propensity score-matched study. World J Emerg Med 12(4):261–267. https://doi.org/10.5847/wjem.j.1920-8642.2021.04.002CrossRefPubMedPubMedCentral

13.

Hobohm L, Becattini C, Ebner M, Lerchbaumer MH, Casazza F, Hasenfuß G, Konstantinides SV, Lankeit M (2020) Definition of tachycardia for risk stratification of pulmonary embolism. Eur J Intern Med 82:76–82. https://doi.org/10.1016/j.ejim.2020.08.009 (Epub 2020 Aug 23)CrossRefPubMed

14.

Barco S, Vicaut E, Klok FA, Lankeit M, Meyer G, Konstantinides SV, PEITHO Investigators (2018) Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials. Eur Respir J. 51(1):1701775. https://doi.org/10.1183/13993003.01775-2017CrossRefPubMed

15.

Sanchez O, Charles-Nelson A, Ageno W, Barco S, Binder H, Chatellier G, Duerschmied D, Empen K, Ferreira M, Girard P, Huisman MV, Jiménez D, Katsahian S, Kozak M, Lankeit M, Meneveau N, Pruszczyk P, Petris A, Righini M, Rosenkranz S, Schellong S, Stefanovic B, Verhamme P, de Wit K, Vicaut E, Zirlik A, Konstantinides SV, Meyer G (2021) Reduced-dose intravenous thrombolysis for acute intermediate-high-risk pulmonary embolism: rationale and design of the pulmonary embolism international THrOmbolysis (PEITHO)-3 trial. Thromb Haemost. https://doi.org/10.1055/a-1653-4699CrossRefPubMedPubMedCentral

Title: Comparison of two scores in predicting pulmonary embolism-related adverse events in intermediate–high-risk patients: a systematic review and meta-analysis
Authors: Carlo Bova
Ernesto Vigna
Massimo Gentile
Francesca Serena Pignataro
Publication date: 23-03-2022
Publisher: Springer International Publishing
Published in: Internal and Emergency Medicine / Issue 5/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-022-02963-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Comparison of two scores in predicting pulmonary embolism-related adverse events in intermediate–high-risk patients: a systematic review and meta-analysis

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2022

Echocardiographic predictors of mortality in intermediate-risk pulmonary embolism

Eight versus 28‑point lung ultrasonography in moderate acute heart failure: comment

Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research

High social media attention scores are not reflective of study quality: an altmetrics-based content analysis

Drug-related emergency department visits: prevalence and risk factors

A bridge too far: are thrombolytics warranted as pre-treatment for endovascular therapy in acute ischemic stroke?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page